Chimerix Drug Patent Portfolio

Chimerix owns 1 orange book drug protected by 7 US patents Given below is the list of Chimerix's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10172862 30 Jan, 2037
Active
US10369154 30 Jan, 2037
Active
US12102639 30 Jan, 2037
Active
US11976068 01 Mar, 2036
Active
US9265765 26 Jul, 2034
Active
US9629842 30 Apr, 2032
Active
USRE46290 30 Apr, 2032
Active


Chimerix's Family Patents


Family Patents



Chimerix Drug List

Given below is the complete list of Chimerix's drugs and the patents protecting them.


1. Modeyso

Modeyso is protected by 7 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10172862 30 Jan, 2037
(11 years from now)
Active
US10369154 30 Jan, 2037
(11 years from now)
Active
US12102639 30 Jan, 2037
(11 years from now)
Active
US11976068 01 Mar, 2036
(10 years from now)
Active
US9265765 26 Jul, 2034
(8 years from now)
Active
US9629842 30 Apr, 2032
(6 years from now)
Active
USRE46290 30 Apr, 2032
(6 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Modeyso's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List